Balaxi Pharmaceuticals Limited (NSE:BALAXI)
India · Delayed Price · Currency is INR 32.30
-1.80 (-5.28%)
Dec 8, 2025, 1:40 PM IST
Balaxi Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 145 | 250.7 | -23.87 | 459.63 | 476.58 | 381.37 | Upgrade |
Depreciation & Amortization | 18.87 | 18.95 | 20.98 | 17.53 | 5.12 | 2.98 | Upgrade |
Other Operating Activities | 116.39 | 59.21 | -55.21 | 51.48 | 19.4 | 27.07 | Upgrade |
Change in Accounts Receivable | -279.75 | -550.92 | -34.23 | -248.01 | 481.34 | -470.45 | Upgrade |
Change in Inventory | 69.97 | 36.87 | 228.55 | -63.2 | -850.86 | -127.86 | Upgrade |
Change in Accounts Payable | -116.27 | -128.6 | -54.81 | -158.07 | 274.07 | 191.46 | Upgrade |
Change in Other Net Operating Assets | 11.28 | -36.25 | -32.76 | 1.4 | -64.21 | -4.55 | Upgrade |
Operating Cash Flow | -34.52 | -350.03 | 48.66 | 60.75 | 341.45 | 0.03 | Upgrade |
Operating Cash Flow Growth | - | - | -19.90% | -82.21% | 1101335.48% | - | Upgrade |
Capital Expenditures | -326.92 | -211.19 | -6.93 | -130.58 | -53.21 | -12.77 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 5.23 | - | - | - | Upgrade |
Cash Acquisitions | -48.49 | -6.45 | -8.77 | -19.22 | -220.23 | -12.79 | Upgrade |
Investment in Securities | - | - | - | - | 34.16 | -34.16 | Upgrade |
Other Investing Activities | - | - | -0 | 44.15 | -45.2 | - | Upgrade |
Investing Cash Flow | -375.4 | -217.64 | -10.46 | -105.65 | -284.48 | -59.73 | Upgrade |
Short-Term Debt Issued | - | - | - | 79.83 | - | 36.59 | Upgrade |
Long-Term Debt Issued | - | 339.63 | 60.4 | - | - | - | Upgrade |
Total Debt Issued | 243.63 | 339.63 | 60.4 | 79.83 | - | 36.59 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | -0.21 | - | Upgrade |
Long-Term Debt Repaid | - | -0.98 | -0.94 | -0.89 | - | - | Upgrade |
Total Debt Repaid | -0.56 | -0.98 | -0.94 | -0.89 | -0.21 | - | Upgrade |
Net Debt Issued (Repaid) | 243.07 | 338.65 | 59.46 | 78.93 | -0.21 | 36.59 | Upgrade |
Issuance of Common Stock | - | 27.05 | 257.9 | 184.71 | - | - | Upgrade |
Common Dividends Paid | - | - | - | -4.98 | - | - | Upgrade |
Other Financing Activities | -53.33 | -26.93 | -14.83 | -3.54 | -1.42 | -0.13 | Upgrade |
Financing Cash Flow | 189.74 | 338.76 | 302.54 | 255.13 | -1.63 | 36.46 | Upgrade |
Miscellaneous Cash Flow Adjustments | 0 | - | 0 | - | - | - | Upgrade |
Net Cash Flow | -220.18 | -228.91 | 340.74 | 210.22 | 55.33 | -23.24 | Upgrade |
Free Cash Flow | -361.44 | -561.23 | 41.74 | -69.83 | 288.23 | -12.74 | Upgrade |
Free Cash Flow Margin | -13.07% | -19.18% | 1.73% | -2.08% | 10.32% | -0.55% | Upgrade |
Free Cash Flow Per Share | -6.52 | -10.17 | 0.81 | -1.38 | 5.76 | -0.26 | Upgrade |
Cash Interest Paid | 45.96 | 27.78 | 15.26 | 3.54 | 1.42 | 0.13 | Upgrade |
Cash Income Tax Paid | 35.52 | 32.11 | 66.81 | 120.94 | 55.92 | 25.95 | Upgrade |
Levered Free Cash Flow | -540.76 | -658.3 | 398.6 | -260.29 | 132.5 | -129.86 | Upgrade |
Unlevered Free Cash Flow | -515.69 | -639.96 | 409.08 | -257.16 | 133.39 | -129.78 | Upgrade |
Change in Working Capital | -314.77 | -678.89 | 106.75 | -467.88 | -159.66 | -411.39 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.